STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
State-of-the-Art Facility Elevates Ophthalmic Education, Empowering Surgeons and Practitioners to Lead the Future of Vision Correction
-
Myopia in the
U.S. has doubled over the past three decades with an expected prevalence of 58.4% by 2050 1 -
EVO ICLTM units, a proxy for procedures, grew by 25% in the
U.S. in 1H 20242 -
More than 700 U.S. surgeons are now certified by
STAAR Surgical to perform EVO ICL2
The new Experience Center is a critical addition to customer training, education and support as the demand for EVO ICL continues to surge among surgeons and refractive practices, driven by the escalating global myopia epidemic. The prevalence of myopia in Americans is 42%3, having doubled over the past three decades3, while laser refractive procedure volume is declining. EVO ICL is rapidly disrupting the refractive market.
“We are thrilled to open our expanded Experience Center, offering cutting-edge resources and training for ophthalmic professionals,” said
The Experience Center elevates the standard of care by equipping healthcare practitioners—MDs, ODs, and support staff—with the tools and knowledge to optimize EVO ICL patient outcomes. It offers advanced visualization and communication technology for both in-person and virtual training. Highlights include:
- Immersive wet lab training stations for up to 24 practitioners, with seating for 59 in lectures
- Stella™, STAAR’s latest innovation in ordering, streamlines and enhances the EVO ICL planning and ordering process
- Advanced diagnostic technology demonstrations, including the OCULUS Pentacam® AXL Wave, IOLMaster 700 and CIRRUS 6000
- 120-inch 4K video array for video conferencing and streaming of remote live surgery to enhance training
The center will officially open on
For more information or to schedule a visit, please contact
For more information about EVO Implantable Collamer® Lenses, visit https://evoicl.com. Connect with us on social media at: Facebook, Instagram, and LinkedIn.
1Bullimore MA, |
2
|
3Banashefski B, Rhee MK, |
About
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in
Important Safety Information
The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0
For additional information with potential benefits, risks and complications please visit DiscoverICL.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240923579067/en/
Media
dholliday@goldpr.com
Investors
Vice President, Investor Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com
Source: